162 related articles for article (PubMed ID: 3427209)
1. Effect of dose and food on the bioavailability of cefuroxime axetil.
Finn A; Straughn A; Meyer M; Chubb J
Biopharm Drug Dispos; 1987; 8(6):519-26. PubMed ID: 3427209
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability of cefuroxime axetil: comparison of standard and abbreviated methods.
Lang CC; Moreland TA; Davey PG
J Antimicrob Chemother; 1990 Apr; 25(4):645-50. PubMed ID: 2351625
[TBL] [Abstract][Full Text] [Related]
3. The absolute bioavailability of oral cefuroxime axetil in male and female volunteers after fasting and after food.
Williams PE; Harding SM
J Antimicrob Chemother; 1984 Feb; 13(2):191-6. PubMed ID: 6706890
[TBL] [Abstract][Full Text] [Related]
4. Effect of two types of Indian breakfast on bioavailability of cefuroxime axetil.
Vasu S; Adithan C; Shashindran CH; Asad M; Koumaravelou K; Topno I
Indian J Med Res; 2000 Sep; 112():104-8. PubMed ID: 11094856
[TBL] [Abstract][Full Text] [Related]
5. Comparative bioavailability of cefuroxime axetil suspension formulations administered with food in healthy subjects.
Mendes GD; Borges A; de Cássia Val L; Patni AK; Reyar S; Monif T; Sereno D; Orellana AM; De Nucci G
Arzneimittelforschung; 2010; 60(2):101-5. PubMed ID: 20329659
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and absolute bioavailability of oral cefuroxime axetil in the rat.
Ruiz-Carretero P; Nacher A; Merino-Sanjuan M; Casabo VG
Int J Pharm; 2000 Jul; 202(1-2):89-96. PubMed ID: 10915930
[TBL] [Abstract][Full Text] [Related]
7. Effect of food on the pharmacokinetics of oral cefuroxime axetil in dogs.
Albarellos GA; Passini SM; Lupi MP; Aramayona S; Lorenzini PM; Montoya L; Landoni MF
J Vet Pharmacol Ther; 2020 May; 43(3):297-302. PubMed ID: 32157713
[TBL] [Abstract][Full Text] [Related]
8. Effect of food on pharmacokinetics of cefuroxime axetil in Chinese subjects.
Chen RR; Lee TY; Hsieh WC
J Formos Med Assoc; 1992 Dec; 91(12):1177-81. PubMed ID: 1363640
[TBL] [Abstract][Full Text] [Related]
9. Penetration of oral cefuroxime axetil into the human aqueous humor.
Ghia M; Lotti R; Traverso C; Mattioli F; Martelli A
Ophthalmologica; 1997; 211(4):229-31. PubMed ID: 9216013
[TBL] [Abstract][Full Text] [Related]
10. Comparative pharmacokinetics of oral ceftibuten, cefixime, cefaclor, and cefuroxime axetil in healthy volunteers.
Nix DE; Symonds WT; Hyatt JM; Wilton JH; Teal MA; Reidenberg P; Affrime MB
Pharmacotherapy; 1997; 17(1):121-5. PubMed ID: 9017772
[TBL] [Abstract][Full Text] [Related]
11. Phosphate binders do not reduce bioavailability of oral cefuroxime-axetil in patients on peritoneal dialysis treatment.
Brink HS; Huisman RM; Geerlings W; de Jong PE
Adv Perit Dial; 1994; 10():179-82. PubMed ID: 7999822
[TBL] [Abstract][Full Text] [Related]
12. Bioavailability of cefuroxime axetil formulations.
Donn KH; James NC; Powell JR
J Pharm Sci; 1994 Jun; 83(6):842-4. PubMed ID: 9120818
[TBL] [Abstract][Full Text] [Related]
13. Comparative investigations on the bioavailability of cefuroxime axetil.
Kees F; Lukassek U; Naber KG; Grobecker H
Arzneimittelforschung; 1991 Aug; 41(8):843-6. PubMed ID: 1781808
[TBL] [Abstract][Full Text] [Related]
14. [Stepwise therapy of community-acquired pneumonia. Results of cefuroxime and cefuroxime axetil study].
Iakovlev SV; Suvorova MP; Dvoretskiĭ LI; Vlasenko NA; Shakhova TV
Antibiot Khimioter; 1998; 43(6):7-11. PubMed ID: 9644527
[TBL] [Abstract][Full Text] [Related]
15. Influence of food and reduced gastric acidity on the bioavailability of bacampicillin and cefuroxime axetil.
Sommers DK; van Wyk M; Moncrieff J; Schoeman HS
Br J Clin Pharmacol; 1984 Oct; 18(4):535-9. PubMed ID: 6091711
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of cefuroxime axetil and cefaclor: relationship of concentrations in serum to MICs for common respiratory pathogens.
James NC; Donn KH; Collins JJ; Davis IM; Lloyd TL; Hart RW; Powell JR
Antimicrob Agents Chemother; 1991 Sep; 35(9):1860-3. PubMed ID: 1952858
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic models for the saturable absorption of cefuroxime axetil and saturable elimination of cefuroxime.
Ruiz-Carretero P; Merino-Sanjuán M; Nácher A; Casabó VG
Eur J Pharm Sci; 2004 Feb; 21(2-3):217-23. PubMed ID: 14757493
[TBL] [Abstract][Full Text] [Related]
18. Bioequivalence evaluation of 2 brands of cefuroxime axetil 250 mg tablets in healthy human volunteers.
Pistos C; Michalea S; Kalovidouris M; Kontopoulos G; Georgarakis M
Int J Clin Pharmacol Ther; 2004 Jul; 42(7):367-72. PubMed ID: 15605688
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and bactericidal activity of cefuroxime axetil.
Ginsburg CM; McCracken GH; Petruska M; Olson K
Antimicrob Agents Chemother; 1985 Oct; 28(4):504-7. PubMed ID: 3878129
[TBL] [Abstract][Full Text] [Related]
20. Model simulation of a single oral dose of cefuroxime axetil and the related in-vitro kill kinetics against four bacterial species.
Silley P; Monsey D; Harris AM
J Antimicrob Chemother; 1990 Jan; 25(1):83-90. PubMed ID: 2180892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
